BEAU RX Trademark

Trademark Overview


On Tuesday, December 1, 2015, a trademark application was filed for BEAU RX with the United States Patent and Trademark Office. The USPTO has given the BEAU RX trademark a serial number of 86835094. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 25, 2024. This trademark is owned by Sterling-Knight Pharmaceuticals, LLC. The BEAU RX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical cream for treating the appearance of scars, namely, a cream to minimize scarring, sold only by prescription
beau rx

General Information


Serial Number86835094
Word MarkBEAU RX
Filing DateTuesday, December 1, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 25, 2024
Registration Number5443766
Registration DateTuesday, April 10, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements


Goods and ServicesPharmaceutical cream for treating the appearance of scars, namely, a cream to minimize scarring, sold only by prescription
NOT AVAILABLE"RX"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 25, 2024
Primary Code005
First Use Anywhere DateThursday, August 31, 2017
First Use In Commerce DateThursday, August 31, 2017

Trademark Owner History


Party NameSterling-Knight Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressRipley, MS 38663

Party NameSterling-Knight Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRipley, MS 38663

Party NameSterling-Knight Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRipley, MS 38663

Trademark Events


Event DateEvent Description
Wednesday, February 17, 2016LETTER OF PROTEST EVIDENCE FORWARDED
Friday, December 4, 2015NEW APPLICATION ENTERED
Friday, December 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 20, 2016ASSIGNED TO EXAMINER
Monday, March 28, 2016LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Tuesday, April 5, 2016NON-FINAL ACTION WRITTEN
Tuesday, April 5, 2016NON-FINAL ACTION E-MAILED
Saturday, November 5, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, April 5, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, November 5, 2016EXAMINERS AMENDMENT -WRITTEN
Saturday, November 5, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 7, 2017SOU EXTENSION 1 GRANTED
Saturday, November 5, 2016EXAMINER'S AMENDMENT ENTERED
Friday, November 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 7, 2017SOU TEAS EXTENSION RECEIVED
Monday, August 7, 2017SOU EXTENSION 1 FILED
Tuesday, January 23, 2018USE AMENDMENT FILED
Friday, February 9, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, March 2, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 3, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 10, 2018REGISTERED-PRINCIPAL REGISTER
Monday, April 10, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 25, 2024CANCELLED SEC. 8 (6-YR)
Monday, February 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 23, 2018TEAS STATEMENT OF USE RECEIVED